ISTO’s Cell Therapies Can Revolutionize Treatment of Joint, Bone Injuries

ISTO Technologies, Inc.is both a regenerative medicine and orthopedics company developing innovative cartilage and bone regeneration products for spinal therapy, sports medicine and trauma. ISTO is currently focused on the development of cell-based cartilage platform technology that can be applied to repair and regenerate damaged cartilage in the knee and spinal disc.

Read more »

Aridis Pharmaceuticals: Better Alternative to Traditional Antibiotics?

Aridis Pharmaceuticals is a private biotechnology company focusing on improved alternatives to traditional antibiotics for the treatment of pneumonia and Cystic Fibrosis in addition to a few other conditions.

Read more »

“Regulatory Rush”-The SEC Lifts The Ban On General Solicitation

On July 10th, 2013 new changes to regulations regarding the general solicitation of securities was announced by the Securities and […]

Read more »

OneMedForum Recap: Del Mar Pharmaceuticals

Delmar Pharmaceuticals (DMPI) is a clinical and early stage Oncologyl Company focused on developing and commercializing leading anti-cancer therapies in high impact orphan oncological indications specifically where patients have failed contemporary therapy.

Read more »

OneMedForum Recap: Pressure Biosciences

Pressure Biosciences (PBIO) is a life sciences company centered on developing and commercializing a novel technology titled Pressure Cycling Technology (PCT).

Read more »

The Fly on the Wall: Athersys Publishes Study on Increasing Survival of Organ Transplants With Stem Cells

Athersys (ATHX) is a clinical stage based biopharmaceutical company with an exponentially growing pipeline and an array of products in therapeutics to treat significant and life-threatening diseases.

Read more »

PR Newswire: BioDelivery Sciences International Secures $20 Million in Debt Financing

A company to keep a look out for in the upcoming future is BioDelivery Sciences International (BDSI), a specialty pharmaceutical company with a platform of drug delivery technologies to develop, commercialize, and improve already proven applications of therapeutics.

Read more »

Global News Wire: Pluristem Therapeutics Forms Strategic Alliance with ChaBio & Diostech

Pluristem Therapeutics (PSTI) is a developer of placenta-based cell therapies. They have just formed a strategic alliance with Cha Bio&Diostech.

Read more »

Global News Wire: Novavax Initiating Human Clinical Trials for H7N9 Virus

Novavax, Inc (NVAX) is a clinical-stage biopharmaceutical company that strives to create novel vaccines to treat a broad spectrum of diseases around the world.

Read more »

Pharma Live: Cytokinetics amending errors in Amyotrophic Lateral Sclerosis Phase IIB Study

Cytokinetics (CYTK) is a clinical stage biotechnology company that focuses on the discovery and development of novel molecular therapeutics in relation to muscle function.

Read more »